Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 43
  • 0 comments

FDA approve METFORMIN HYDROCHLORIDE

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 40
  • 0 comments

FDA approve RIZATRIPTAN BENZOATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 34
  • 0 comments

FDA approve AMOXICILLIN

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 42
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

INVENTIA

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 42
  • 0 comments

FDA approve NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

Comment Full text

VISTAPHARM

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 42
  • 0 comments

FDA approve PHENYTOIN

Comment Full text

ENCUBE

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve MESALAMINE

Comment Full text

LUPIN LTD

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve RIFABUTIN

Comment Full text

AVET LIFESCIENCES

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 46
  • 0 comments

FDA approve RIFAMPIN

Comment Full text

LEADING

  • FDA Approval
  • April 16, 2024, 08:49 UTC
  • 44
  • 0 comments

FDA approve HYDROXYUREA

Comment Full text
  • Previous
  • 476
  • 477
  • 478
  • 479
  • 480
  • Next

Search

News categories

  • Technical Exchange News(12448)
  • Event(6229)
  • SEC News(278889)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(160224)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin